{"classes":[{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"7560.10","upperLimit":"284312.37","value":"143728.793"}]}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"25"}],"units":"Participants"}],"description":"Measurement of NY-ESO-1ᶜ²⁵⁹T cells in blood","dispersionType":"Full Range","groups":[{"description":"Participants who received NYESO-1ᶜ²⁵⁹T following ASCT","id":"OG000","title":"NYESO-1ᶜ²⁵⁹T Cells"}],"paramType":"MEAN","populationDescription":"Participants who received NYESO-1ᶜ²⁵⁹T following ASCT","reportingStatus":"POSTED","timeFrame":"Post-infusion through Day 42","title":"Peak Persistence of Modified T-cells in the Peripheral Blood","type":"SECONDARY","unitOfMeasure":"copies per μg of DNA"}